In addition to CD133, CD44, EpCAM, and CD166, the expression of leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) varies among colorectal cancer (CRC) cases and is significantly correlated with lymphatic and vascular invasion, lymph node metastasis, and drug resistance (Vermeulen et al., 2008; Merlos-Suarez et al., 2011; Kobayashi et al., 2012). This evidence concerns the gene LGR5 and colorectal carcinoma.